Effect of Bitter Melon's Extract Fraction (Momordica Charantia L.) on Blood Sugar Reduction, Insulin Resistance and Phosphatidyl Inositol 3-Kinase (PI3K) Signalling in Male Rats (Rattus novergicus) Streptozotocin-Induced Hyperglycemia
DOI:
https://doi.org/10.59188/jurnalsosains.v4i3.1256Keywords:
bitter melon, diabetes mellitus, insulin resistance, phosphatidyl inositol 3-kinase, streptozotocinAbstract
Background: Diabetes mellitus (DM) is a metabolic disease characterized by symptoms of hyperglycemia as a result of impaired insulin secretion. The main cause of type 2 diabetes mellitus is metabolic disorders characterized by insulin receptor resistance, reduced ability of β-pancreatic cells to secrete insulin, and abnormalities in insulin secretion from pancreatic β islet of Langerhans cells. In insulin resistance, the presence of impaired signaling in Phosphatidylinositol 3-kinase (PI3K) disrupts glucose regulation in the body. The purpose of this study was to determine the effect of bitter melon extract (Momordica charantia L.) on blood sugar reduction, insulin resistance and phosphatidyl inositol 3-kinase (PI3K) signaling.
Purpose : The objectives of this study are Effect of Bitter Melon's Extract Fraction (Momordica Charantia L.) on Blood Sugar Reduction, Insulin Resistance and Phosphatidyl Inositol 3-Kinase (PI3K) Signalling in Male Rats (Rattus novergicus) Streptozotocin-Induced Hyperglycemia
Method: This study used a type of laboratory experimental research post-test randomized controlled group design on hyperglycemic male rats (Rattus novergicus). All data analysis is done using SPSS software.
Results: Based on research conducted, it is known that bitter melon extract affects blood sugar, insulin resistance and PI3K signaling.
Conclusion: Bitter melon extract has potential as an herbal antidiabetic remedy
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Gustiany Nadya Damanik
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
